Table 3.
Relation between SBP measured by different tools monitoring and early hypertensive end organ damage
| ABPM | P value | Central | P value | |||
|---|---|---|---|---|---|---|
| Controlled | Not controlled | Controlled | Not controlled | |||
| No. (%) | No. (%) | No. (%) | No. (%) | |||
| ECG | ||||||
| Normal | 48 (96%) | 13 (26%) | 0.000** | 49 (90.7%) | 12 (26.1%) | 0.000** |
| LVH | 2 (4%) | 34 (68%) | 5 (9.3%) | 31 (67.4%) | ||
| LBBB | 0 (0%) | 3 (6%) | 0 (0%) | 3 (6.5%) | ||
| LVMI | ||||||
| Normal | 47 (94%) | 37 (74%) | 0.006** | 52 (96.3%) | 32 (69.6%) | 0.000** |
| Abnormal | 3 (6%) | 13 (26%) | 2 (3.7%) | 14 (30.4%) | ||
| CIMT | ||||||
| Normal | 47 (94%) | 37 (74%) | 0.006** | 51 (94. 4%) | 33 (71.7%) | 0.002** |
| Abnormal | 3 (6%) | 13 (26%) | 3 (5. 6%) | 13 (28.3%) | ||
| PWV | ||||||
| Normal | 50 (100%) | 43 (86%) | 0.006** | 54 (100%) | 39 (84.8%) | 0.003** |
| Abnormal | 0 (0%) | 7 (14%) | 0 (0%) | 7 (15. 2%) | ||
| ABI | ||||||
| Normal | 39 (78%) | 21 (42%) | 0.000** | 41 (75.9%) | 19 (41.3%) | 0.000** |
| Abnormal | 11 (22%) | 29 (58%) | 13 (24.1%) | 27 (58.7%) | ||
| Creatinine | ||||||
| Normal | 47 (94%) | 30 (60%) | 0.000** | 52 (96.3%) | 25 (54.3%) | 0.000** |
| Abnormal | 3 (6%) | 20 (40%) | 2 (3.7%) | 21 (45.7%) | ||
| GFR | ||||||
| Normal | 47 (94%) | 36 (72%) | 0.003** | 50 (92.6%) | 33 (71.7%) | 0.006** |
| Abnormal | 3 (6%) | 14 (28%) | 4 (7.4%) | 13 (28.3%) | ||
Chi-square test
*Statistically significant difference (p < 0.05)
**Highly statistically significant difference (p < 0.01)
HTN hypertension, ABPM ambulatory blood pressure monitoring, PWV pulse wave velocity, Cr creatinine, GFR glomerular filtration ratio, LVMI left ventricular mass index, CIMT carotid intimal thickness, ABI ankle-brachial index